Volume 22, Issue 3 pp. 359-363
Clinical Review

Ventricular Tachycardia in the Era of Ventricular Assist Devices

DAVID A. CESARIO M.D., Ph.D.

DAVID A. CESARIO M.D., Ph.D.

CardioVascular Thoracic Institute (CVTI) at the Keck School of Medicine, University of Southern California, Los Angeles, California, USA

Search for more papers by this author
LESLIE A. SAXON M.D.

LESLIE A. SAXON M.D.

CardioVascular Thoracic Institute (CVTI) at the Keck School of Medicine, University of Southern California, Los Angeles, California, USA

Search for more papers by this author
MICHAEL K. CAO M.D.

MICHAEL K. CAO M.D.

CardioVascular Thoracic Institute (CVTI) at the Keck School of Medicine, University of Southern California, Los Angeles, California, USA

Search for more papers by this author
MICHAEL BOWDISH M.D.

MICHAEL BOWDISH M.D.

CardioVascular Thoracic Institute (CVTI) at the Keck School of Medicine, University of Southern California, Los Angeles, California, USA

Search for more papers by this author
MARK CUNNINGHAM M.D.

MARK CUNNINGHAM M.D.

CardioVascular Thoracic Institute (CVTI) at the Keck School of Medicine, University of Southern California, Los Angeles, California, USA

Search for more papers by this author
First published: 19 October 2010
Citations: 28
Address for correspondence: David A. Cesario, M.D., Ph.D., Division of Cardiovascular Medicine, Keck School of Medicine, University of Southern California, 1510 San Pablo St. #322 North, HCC I, Los Angeles, CA 90033, USA. Fax: 323-442-6133; E-mail: [email protected]

David Cesario reports honoraria from Boston Scientific and Medtronic; Leslie A. Saxon reports honoraria from Boston Scientific and Medtronic; Michael Cao reports honoraria from Boston Scientific; Michael Bowdish reports participation on research grants supported by Terumo Heart, Inc. and Jarvik Heart, Inc.; Mark Cunningham reports participation on a research grant supported by Terumo Heart, Inc. and honoraria from Medtronic and St. Jude Medical.

Editor: Stephen C. Hammill, M.D.

Abstract

Ventricular Tachycardia in the Era of Ventricular Assist Devices. Sustained ventricular tachycardia (VT) in patients with advanced cardiomyopathy is a potentially life-threatening arrhythmia. Newer treatment strategies have evolved that combine the use of catheter ablation to target the substrate for VT and ventricular assist devices (VADs) to hemodynamically support the failing ventricle. This editorial is targeted to the practicing clinician caring for these difficult patients. The current article reviews the use of percutaneous VADs to support catheter ablation of VT, the use of durable VADs to support the failing heart in patients with recurrent VT, ventricular arrhythmias in patients with durable VADs, and the use of catheter ablation to treat VT in patients with durable VADs. (J Cardiovasc Electrophysiol, Vol. 22, pp. 359-363, March 2011)

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.